Repository logo
 

Assessing New York City's COVID-19 Vaccine Rollout Strategy: A Case for Risk-Informed Distribution.

dc.contributor.authorSchwalbe, Nina
dc.contributor.authorNunes, Marta C
dc.contributor.authorCutland, Clare
dc.contributor.authorWahl, Brian
dc.contributor.authorReidpath, Daniel
dc.date.accessioned2024-04-30T12:26:45Z
dc.date.available2024-04-30T12:26:45Z
dc.date.issued2024-04-05
dc.date.updated2024-04-18T01:27:48Z
dc.descriptionFrom PubMed via Jisc Publications Router
dc.descriptionHistory: accepted 2024-03-08
dc.descriptionPublication status: aheadofprint
dc.descriptionDaniel Reidpath - ORCID: 0000-0002-8796-0420 https://orcid.org/0000-0002-8796-0420
dc.description.abstractThis study reviews the impact of eligibility policies in the early rollout of the COVID-19 vaccine on coverage and probable outcomes, with a focus on New York City. We conducted a retrospective ecological study assessing age  65+, area-level income, vaccination coverage, and COVID-19 mortality rates, using linked Census Bureau data and New York City Health administrative data aggregated at the level of modified zip code tabulation areas (MODZCTA). The population for this study was all individuals in 177 MODZCTA in New York City. Population data were obtained from Census Bureau and New York City Health administrative data. The total mortality rate was examined through an ordinary least squares (OLS) regression model, using area-level wealth, the proportion of the population aged 65 and above, and the vaccination rate among this age group as predictors. Low-income areas with high proportions of older people demonstrated lower coverage rates (mean vaccination rate 52.8%; maximum coverage 67.9%) than wealthier areas (mean vaccination rate 74.6%; maximum coverage 99% in the wealthiest quintile) in the first 3 months of vaccine rollout and higher mortality over the year. Despite vaccine shortages, many younger people accessed vaccines ahead of schedule, particularly in high-income areas (mean coverage rate 60% among those 45-64 years in the wealthiest quintile). A vaccine program that prioritized those at greatest risk of COVID-19-associated morbidity and mortality would have prevented more deaths than the strategy that was implemented. When rolling out a new vaccine, policymakers must account for local contexts and conditions of high-risk population groups. If New York had focused limited vaccine supply on low-income areas with high proportions of residents 65 or older, overall mortality might have been lower. [Abstract copyright: © 2024. The Author(s).]
dc.description.ispublishedpub
dc.description.number5
dc.description.statuspub
dc.description.volume101
dc.format.extent923–933
dc.identifierpubmed: 38578336
dc.identifierdoi: 10.1007/s11524-024-00853-z
dc.identifierpii: 10.1007/s11524-024-00853-z
dc.identifierhttps://eresearch.qmu.ac.uk/handle/20.500.12289/13724/13724.pdf
dc.identifier.citationSchwalbe, N., Nunes, M.C., Cutland, C., Wahl, B. and Reidpath, D. (2024) ‘Assessing new york city’s covid-19 vaccine rollout strategy: a case for risk-informed distribution’, Journal of Urban Health, 101(5), pp. 923–933. Available at: https://doi.org/10.1007/s11524-024-00853-z.
dc.identifier.urihttps://eresearch.qmu.ac.uk/handle/20.500.12289/13724
dc.identifier.urihttps://doi.org/10.1007/s11524-024-00853-z
dc.languageeng
dc.rightsOpen Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
dc.rights.licenseCC BY 4.0 DEED Attribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceeissn: 1468-2869
dc.subjectNew York City
dc.subjectMorbidity
dc.subjectSpacial Analysis
dc.subjectVaccination Coverage
dc.subjectNew York
dc.subjectSARS-CoV-2
dc.subjectVaccination
dc.subjectUrban Health
dc.subjectRisk Factors
dc.subjectVaccines
dc.subjectImmunization
dc.subjectEconomic Status
dc.subjectCoverage
dc.subjectAged
dc.subjectCOVID-19 Vaccines
dc.subjectPoverty
dc.subjectHealth Policy
dc.subjectSocial Risk Factors
dc.subjectCensuses
dc.subjectCOVID-19
dc.titleAssessing New York City's COVID-19 Vaccine Rollout Strategy: A Case for Risk-Informed Distribution.
dc.typearticle
dcterms.accessRightspublic
dcterms.dateAccepted2024-03-08
qmu.authorReidpath, Daniel
qmu.centreInstitute for Global Health and Development
refterms.dateAccepted2024-03-08
refterms.dateDeposit2024-04-30
refterms.depositExceptionpublishedGoldOA
refterms.versionVoR
rioxxterms.publicationdate2024-04-05
rioxxterms.versionVoR

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
13724.pdf
Size:
793.09 KB
Format:
Adobe Portable Document Format
Description:
Published Version